These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26338207)

  • 1. Cyclometalated Ruthenium(II) Anthraquinone Complexes Exhibit Strong Anticancer Activity in Hypoxic Tumor Cells.
    Zeng L; Chen Y; Huang H; Wang J; Zhao D; Ji L; Chao H
    Chemistry; 2015 Oct; 21(43):15308-19. PubMed ID: 26338207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ruthenium(II) polypyridyl complexes: cellular uptake, cell image and apoptosis of HeLa cancer cells induced by double targets.
    Yu Q; Liu Y; Xu L; Zheng C; Le F; Qin X; Liu Y; Liu J
    Eur J Med Chem; 2014 Jul; 82():82-95. PubMed ID: 24878637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling.
    Zhao Z; Luo Z; Wu Q; Zheng W; Feng Y; Chen T
    Dalton Trans; 2014 Dec; 43(45):17017-28. PubMed ID: 25087850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-Targeting Organometallic Ru(II)-Arene Complexes with Enhanced Anticancer Activity in Hypoxic Cancer Cells.
    Zhao J; Li W; Gou S; Li S; Lin S; Wei Q; Xu G
    Inorg Chem; 2018 Jul; 57(14):8396-8403. PubMed ID: 29953210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization and anticancer mechanism studies of fluorinated cyclometalated ruthenium(ii) complexes.
    Wen Y; Ouyang C; Li Q; Rees TW; Qiu K; Ji L; Chao H
    Dalton Trans; 2020 Jun; 49(21):7044-7052. PubMed ID: 32406463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor activity and mechanism of apoptosis of A549 induced by ruthenium complex.
    Sun D; Mou Z; Li N; Zhang W; Wang Y; Yang E; Wang W
    J Biol Inorg Chem; 2016 Dec; 21(8):945-956. PubMed ID: 27620172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-Sensitive Metal β-Ketoiminato Complexes Showing Induced Single-Strand DNA Breaks and Cancer Cell Death by Apoptosis.
    Lord RM; Hebden AJ; Pask CM; Henderson IR; Allison SJ; Shepherd SL; Phillips RM; McGowan PC
    J Med Chem; 2015 Jun; 58(12):4940-53. PubMed ID: 25906293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imine-N-Heterocyclic Carbenes as Versatile Ligands in Ruthenium(II) p-Cymene Anticancer Complexes: A Structure-Activity Relationship Study.
    Yang Y; Guo L; Tian Z; Liu X; Gong Y; Zheng H; Ge X; Liu Z
    Chem Asian J; 2018 Oct; 13(19):2923-2933. PubMed ID: 30101417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorinated cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents.
    Ouyang M; Zeng L; Huang H; Jin C; Liu J; Chen Y; Ji L; Chao H
    Dalton Trans; 2017 May; 46(20):6734-6744. PubMed ID: 28488721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ru(II) complexes bearing guanidinium ligands as potent anticancer agents.
    Chen WX; Song XD; He SF; Sun J; Chen JX; Wu T; Mao ZW
    J Inorg Biochem; 2016 Nov; 164():91-98. PubMed ID: 27666421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-binding, cytotoxicity in vitro and cell cycle arrest of ruthenium(II) polypyridyl complexes.
    Liu SH; Zhu JW; Xu HH; Wang Y; Liu YM; Liang JB; Zhang GQ; Cao DH; Lin YY; Wu Y; Guo QF
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 May; 161():77-82. PubMed ID: 26956530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10]phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor Cells.
    Zeng L; Chen Y; Liu J; Huang H; Guan R; Ji L; Chao H
    Sci Rep; 2016 Jan; 6():19449. PubMed ID: 26763798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, Characterization, and in Vitro Antitumor Activity of Ruthenium(II) Polypyridyl Complexes Tethering EGFR-Inhibiting 4-Anilinoquinazolines.
    Du J; Kang Y; Zhao Y; Zheng W; Zhang Y; Lin Y; Wang Z; Wang Y; Luo Q; Wu K; Wang F
    Inorg Chem; 2016 May; 55(9):4595-605. PubMed ID: 27093574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hypoxia efficient imidazole-based Ru(II) arene anticancer agent resistant to deactivation by glutathione.
    Purkait K; Karmakar S; Bhattacharyya S; Chatterjee S; Dey SK; Mukherjee A
    Dalton Trans; 2015 Apr; 44(13):5969-73. PubMed ID: 25742181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iminoamido chelated iridium(III) and ruthenium(II) anticancer complexes with mitochondria-targeting ability and potential to overcome cisplatin resistance.
    Guo L; Li P; Jing Z; Gong Y; Lai K; Fu H; Dong H; Yang Z; Liu Z
    J Inorg Biochem; 2024 Sep; 258():112631. PubMed ID: 38843774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel cyclometalated Ru(II) complexes containing isoquinoline ligands: Synthesis, characterization, cellular uptake and in vitro cytotoxicity.
    Chen J; Wang J; Deng Y; Li B; Li C; Lin Y; Yang D; Zhang H; Chen L; Wang T
    Eur J Med Chem; 2020 Oct; 203():112562. PubMed ID: 32698112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterobimetallic Ru(ii)/Fe(ii) complexes as potent anticancer agents against breast cancer cells, inducing apoptosis through multiple targets.
    Guedes APM; Mello-Andrade F; Pires WC; de Sousa MAM; da Silva PFF; de Camargo MS; Gemeiner H; Amauri MA; Gomes Cardoso C; de Melo Reis PR; Silveira-Lacerda EP; Batista AA
    Metallomics; 2020 Apr; 12(4):547-561. PubMed ID: 32108850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial fragmentation is an important cellular event induced by ruthenium(II) polypyridyl complexes in osteosarcoma cells.
    Du Y; Fu X; Li H; Chen B; Guo Y; Su G; Zhang H; Ning F; Lin Y; Mei W; Chen T
    ChemMedChem; 2014 Apr; 9(4):714-8. PubMed ID: 24403015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serendipitous Synthesis of Five-Coordinated Half-Sandwich Aminoimine Iridium(III) and Ruthenium(II) Complexes and Their Application as Potent Anticancer Agents.
    Du Q; Guo L; Ge X; Zhao L; Tian Z; Liu X; Zhang F; Liu Z
    Inorg Chem; 2019 May; 58(9):5956-5965. PubMed ID: 30986046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strained ruthenium complexes are potent light-activated anticancer agents.
    Howerton BS; Heidary DK; Glazer EC
    J Am Chem Soc; 2012 May; 134(20):8324-7. PubMed ID: 22553960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.